Hanna P. Lesch has served in a dual role as research and development director at FinVector Vision Therapies and sister company FKD Therapies since 2013. With more than 15 years’ experience in the field of Gene Therapy and vector development, Lesch began her career developing preclinical Gene Therapy approaches and scalable viral vector processes. She holds a PhD in Molecular Medicine from the University of Kuopio, and completed post doctorate work at the University of California San Diego and University of Eastern Finland. Lesch is also active in the industry, with multiple publications, and patents covering baculovirus mediated lentivirus production.